-
Loading metrics
Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy
- Sasagu Kurozumi,
- Yuri Yamaguchi,
- Hiroshi Matsumoto,
- Masafumi Kurosumi,
- Shin-ichi Hayashi,
- Takaaki Fujii,
- Jun Horiguchi,
- Ken Shirabe,
- Kenichi Inoue
x
- Published: May 21, 2019
- https://doi.org/10.1371/journal.pone.0217279